Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Panitumumab on the Pharmacokinetics of Irinotecan
- Status
- COMPLETED
- Phase
- PHASE1
Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Efficacy Study of AZD6244 in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases
- Status
- COMPLETED
- Phase
- NA
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3